$3.17
▼ -13.4% Today
as of Oct 22, 16:46 ET
Last 30 days
Recent Press Releases & News
bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
BIAF earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±6.3% on average; after the most recent report on May 8, 2026 it moved -4.2%. The share price of $3.17 sits near its 52-week low.
Overview
52-week range
$3.14
$81
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-6.3%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.64 | — | — | — | — | financials |
| Fri May 8, 2026 | Mar/2026 | $-0.81 | — | — | -406.2% | -4.2% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-2.70 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.13 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.16 | — | — | — | -8.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-4.84 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.19 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.20 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.26 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.20 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.18 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | — | $1M | $1M | $2M | — | $2M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-4M | — | $-2M | $-3M | $-3M | — | $-2M |
| Net income | $-3M | $-4M | — | $-5M | $-4M | $-3M | — | $-2M |
| EPS (diluted) | $-0.64 | $-0.81 | — | $-4.74 | $-5.07 | $-4.80 | — | $-4.84 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $3M | $6M | $8M | $802,835 | $444,706 | $1M | $756,580 |
| Inventory | $82,378 | $77,887 | $53,548 | $35,234 | $43,971 | $38,782 | $27,608 | $25,363 |
| Total current assets | $4M | $4M | $8M | $9M | $2M | $2M | $3M | $3M |
| Total assets | $8M | $8M | $11M | $12M | $5M | $6M | $7M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $4M | $4M | $3M | $7M | $4M | $4M | $3M |
| Total equity | $4M | $4M | $7M | $9M | $-2M | $1M | $3M | $3M |
Implied volatility — last 90 days
No IV snapshots yet for BIAF.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
BIAF earnings FAQ
How does BIAF stock usually react to earnings?
Across the last 2 reports the average next-day move was ±6.3%, up 0 times and down 2 times.